Hi Captain Blood and Domma. Recently I directed you to OBJ's Website, ASX listed Announcements and the Advanced Search function on Hotcopper as a place to begin your research on OBJ. After reading your above post Captain Blood, metaphorically it reminded me of a piece of swiss cheese; so perhaps you need a nudge in the right direction. All the hard work has already been done for but nobody is going to hand feed you. You must take the leap and follow the suggestions. This is an open forum where like-minded adults congregate to share information and research. Where this information has already been previously researched and shared, it makes good sense to take advantage of the energy that has already been exerted while OBJ has been in the Research & Development phase. You have to put in an effort. All that is required is a little search. Realising that some here have different educational backgrounds and the Advanced Search function has been playing up lately on Hotcopper, I have taken the liberty to highlight just a sample of posts over the last couple of years (recent in terms of the 10+ years of the R&D phase) from some of our more experienced contributors. There are many others that have continued to make valued contributions including myself. The below links are the ones that I have appreciated recently:
Abdm - This post contains dozens of further links including A Qualitative Analysis: 2014 http://hotcopper.com.au/threads/shareholder-update.2236080/?post_id=13313105#.Vuigl-J95xA
Blackiwi - Bodyguard: http://hotcopper.com.au/threads/kneeguard-results.2706187/?post_id=17078440#.VuihVuJ95xA
GBR - P&G: http://hotcopper.com.au/threads/the....2549791/page-2?post_id=15602140#.VuikLOJ95xA
Jasetheace40 - Patents: http://hotcopper.com.au/threads/p-g’s-magnetic-brand-strategy.2385919/?post_id=14170975#.Vuil4-J95xA
And Domma in relation to your question 'Is anyone concerned by the increased loss and lower cash reserves?'........No. When any company is transitioning from R&D to Commercialisation this is typical. OBJ have $8.8 million in cash, no debt & $540K quarterly spend (enough funds to last 4 years without revenue - although revenue & Licensing deals are imminent). OBJ is in a particularly envious position due to the fact that all of OBJ's partner collaborations are partner funded, where partners currently pay for all of the product research & development/clinical trials/Commercialisation; and OBJ receives licensing fees & royalties on every product. As OBJ are partnering with the largest companies on the planet with established billion dollar brands; OBJ are in a position to shortly start producing revenue; with the very real potential to become cash-flow positive based on one product........and at last count OBJ has well over 20 products under development across at least 6 heavy hitting global partners, with at least 12 products sitting with Procter & Gamble alone.
The ride from here on out is going to be a very bumpy one. Lots of ups and down as attested from just the last couple of days. OBJ is on alot of radars which now includes Fund Managers, Institutions, Sophisticated, Retail, Traders, Swing Traders, Short/Medium/Long, so don't expect an easy straight line up. At the recent CR, OBJ only raised what they forecast they will need and Institutions were left begging. The recent Roadshow was only to show-case OBJ's achievements to date and let the Market know that there are several Product Licensing deals imminent. You are effectively buying a ticket on a roller-coaster........so if you do purchase, don't forget to buckle up .
- Forums
- ASX - By Stock
- WFL
- somebody queue jumping to buy shares
somebody queue jumping to buy shares, page-201
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable